Mar 30, 2020 · 1h 24m · capital-allocators
Ben Inker – Value Investing at GMO (First Meeting, EP.17)
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of Capital Allocators, host Ted Seides interviews GMO's Head of Asset Allocation Ben Inker to explore the mathematical foundation of value investing, the adaptation of quantitative models in an intangible economy, and the behavioral discipline required for institutional portfolio construction. Inker shares formative lessons from legendary mentors and provides strategic frameworks for navigating market dislocations, corporate monopolies, and allocator cognitive biases.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Ted holds 16.2% of the talking time here. How this is scored →
speaking balance: gold is Ted, purple is the guest (3 minute bins)
Ben forcefully dismisses the common allocator assumption that taking a public company private and re-listing it automatically earns an illiquidity premium.
Hardest push from Ted ▶ 35:34 Ted pushes back with Tepper's monopoly concentration argumentTed directly challenges Ben's thesis on mean-reverting margins by citing industry concentration and regulatory moats as structural reasons for persistent tech dominance.
Biggest teaching moment ▶ 45:30 Ben debunks productivity growth assumptions with manufacturing dataBen provides a detailed empirical breakdown revealing that US manufacturing productivity growth has been net negative since 2011, overturning standard economic narratives.
Ted holds their own ▶ 35:34 Ted frames the natural monopoly and profit margin problemTed demonstrates deep macroeconomic knowledge by synthesizing industrial concentration literature into a sharp, multi-layered question on tech margins.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Ted as informed peer | Guest teaching | Guest disagreement | Ted pushing back | Why |
|---|---|---|---|---|---|---|
| Formative Yale Mentors: Lessons from Shiller and Tobin | 4 | 5 | 1 | 0 | Ted prompts Ben on his academic background at Yale with Shiller and Tobin. Ben explains key conceptual lessons on market volatility and replacement costs in an educational manner. | |
| David Swenson Mentorship and Getting Hired at GMO | 3 | 4 | 1 | 0 | Ben narrates his humorous origin story involving David Swensen and how Jeremy Grantham reluctantly hired him straight out of undergraduate studies. Ted listens and facilitates the narrative. | |
| GMO Investment Philosophy: Relentlessly Probing Why and How | 5 | 4 | 2 | 1 | Ted probes into GMO's philosophical core and how Ben found his footing. Ben stresses the discipline of relentlessly asking why and how rather than blindly running models. | |
| Synergy Between Quantitative Frameworks and Fundamental Research | 6 | 4 | 2 | 2 | Ted compares the current market regime to the late 1990s tech bubble. Ben details the complementary nature of quantitative and fundamental research and explains differences in client sentiment. | |
| The Value Thesis and Global Valuation Spreads Today | 6 | 5 | 2 | 1 | Ted asks why investors will get paid for owning value today. Ben deconstructs the limits of giant tech growth like Google and highlights wider valuation spreads outside the US. | |
| Sponsor Announcement: Ridgeline Investment Management Technology Platform | 7 | 5 | 3 | 3 | Ted cites Jonathan Tepper's thesis on industry concentration to challenge whether profit margins will stay permanently elevated. Ben agrees secular concentration exists but argues antitrust policy will eventually reverse it. | |
| Accounting for Intangibles and Evaluating Returns to Scale | 5 | 5 | 2 | 1 | Ted asks how GMO accounts for technological disruption and intangible assets. Ben explains the adjustment of accounting metrics and critiques the SoftBank Vision Fund approach of trying to buy market dominance. | |
| Interest Rates, Equity Duration, and the Productivity Paradox | 6 | 7 | 3 | 1 | Ben reframes the consensus view on interest rates and equity duration, demonstrating that lower rates may imply lower returns on capital rather than long-duration advantages for growth stocks, backed by negative manufacturing productivity data. | |
| Why Quantitative Capital Has Fled the Value Factor | 6 | 5 | 2 | 2 | Ted asks why quantitative capital hasn't arbitraged away wide value spreads. Ben explains how backward-looking backtests cause quants and capital flows to abandon underperforming factors. | |
| M&A Dynamics and the Disappearing Value Takeover Premium | 6 | 5 | 2 | 2 | Ted pushes Ben on whether business realities have fundamentally broken value factor assumptions. Ben analyzes empirical takeover data and shows private equity shifted from cheap value targets to growth targets. | |
| Allocator Pitfalls and Debunking the Illiquidity Premium Myth | 6 | 8 | 4 | 1 | Ben aggressively debunks the institutional concept of an illiquidity premium in private equity LBOs, showing that making an asset temporarily private and taking it public again does not inherently generate a fundamental liquidity premium. | |
| Institutional Portfolio Construction and Long-Term Time Horizon | 6 | 5 | 2 | 1 | Ted asks how an institutional allocator should structure a portfolio today. Ben details the necessity of aligning risk capacity with institutional mission and long time horizons. | |
| Crisis Update: COVID-19 Market Shock and Opportunity | 5 | 6 | 3 | 1 | In a COVID-19 shock follow-up and closing questions, Ben outlines the anatomy of bear markets and sharply critiques allocators who misuse terminology and extrapolate backward-looking bond returns. |